Authors:
Geva, E
Yaron, Y
Shomrat, R
Ben-Yehuda, A
Zabari, S
Peretz, H
Naiman, T
Yeger, H
Orr-Urtreger, A
Citation: E. Geva et al., The risk of Fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known Fragile X families, GENET TEST, 4(3), 2000, pp. 289-292
Authors:
Horowitz, M
Pasmanik-Chor, M
Borochowitz, Z
Falik-Zaccai, T
Heldmann, K
Carmi, R
Parvari, R
Beit-Or, H
Goldman, B
Peleg, L
Levy-Lahad, E
Renbaum, P
Legum, S
Shomrat, R
Yeger, H
Benbenisti, D
Navon, R
Dror, V
Shohat, M
Magal, N
Navot, N
Eyal, N
Citation: M. Horowitz et al., Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewishpopulation (vol 12, pg 240, 1998), HUM MUTAT, 13(3), 1999, pp. 255-255
Citation: P. Rozen et al., Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9, GUT, 45(6), 1999, pp. 829-833
Authors:
Rozen, P
Shomrat, R
Strul, H
Naiman, T
Karminsky, N
Legum, C
Orr-Urtreger, A
Citation: P. Rozen et al., Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer, GASTROENTY, 116(1), 1999, pp. 54-57
Authors:
Barel, D
Cohen, IJ
Mor, C
Stern, S
Shapiro, R
Shomrat, R
Galanti, Y
Legum, C
Zaizov, R
Avigad, S
Citation: D. Barel et al., Mutations of the adenomatous polyposis coli and p53 genes in a child with Turcot's syndrome, CANCER LETT, 132(1-2), 1998, pp. 119-125